Skip to content

Effect of low-dose remifentanil pumped after operation on restlessness and hemodynamics in patients with hypertension during Allen Su during thoracoscopic lobectomy

Effect of low-dose remifentanil pumped after operation on restlessness and hemodynamics in patients with hypertension during Allen Su during thoracoscopic lobectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092060
Enrollment
Unknown
Registered
2024-11-08
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restlessness

Interventions

A group:Remifentanil was infused at 1/8 of the basal rate until 10 min after extubation
B group:Remifentanil was infused at 1/4 of the basal rate until 10 min after extubation
C group:Remifentanil was infused at 1/2 of the basal rate until 10 min after extubation
D group:Remifentanil infusion was stopped at the end of operation and normal saline was infused at 1/2 of the basal rate until 10min after extubation

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Thoracoscopic lobectomy was performed for preoperative diagnosis of pulmonary space occupying or pulmonary nodules 2. A history of hypertension was clearly diagnosed in the past 3. Age 18-80 years old 4. BMI 18-30 kg/m2 5. ASA Grade I-II 6. Those who voluntarily join and sign informed consent after fully explaining the contents of clinical trials

Exclusion criteria

Exclusion criteria: 1. Mental or neurological disorders 2. Any previous mental illness 3. Visual, auditory, language or other obstacles to communication and evaluation 4. Use analgesics or receive psychotropic drugs 5. Study related drug allergies 6. Opioid contraindications 7. Refuse to use postoperative analgesia 8. Skin infection or systemic infection near the puncture site, etc. 9. Patients with severe pulmonary hypertension, arrhythmia or cardiac insufficiency; Patients with liver and kidney function; Or increased intracranial pressure or intraocular pressure

Design outcomes

Primary

MeasureTime frame
Riker sedation and restlessness score;Restlessness score in Allen Su period;RPP and PRQ;

Secondary

MeasureTime frame
Visual Analogue Scale (VAS) pain score;The first PCA time and the number of analgesic pump presses within 48 hours after surgery;Accumulated consumption of postoperative analgesics and frequency of remedial analgesia;Postoperative complications such as dizziness, nausea, vomiting, respiratory depression, and skin itching;AICU stay time and postoperative hospitalization days of subjects;Spontaneous breathing recovery time, Allen Su time, extubation time;Cough during extubation;

Countries

China

Contacts

Public ContactLi Rui

The Second Affiliated Hospital of Anhui Medical University

lrayd@sina.com+86 138 5511 4159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026